NCT00066092 - Pegfilgrastim PBPC Mobilization Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

October 31, 2004

Conditions

LymphomaHodgkin's LymphomaNon-Hodgkin's LymphomaHematologyOncology

Interventions

DRUG

pegfilgrastim 12 mg

Pegfilgrastim 12 mg given once for PBPC mobilization

DRUG

filgrastim

Filgrastim given daily for PBPC mobilization

DRUG

pegfilgrastim 6 mg

Pegfilgrastim 6 mg given once for PBPC mobilization